These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9029660)

  • 1. The role of neurocognitive deficits in understanding adaptive functioning in severe psychiatric illness: commentary on Hawkins and Cooper.
    Nuechterlein KH; Subotnik KL
    Psychiatry; 1996; 59(4):389-92. PubMed ID: 9029660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive neuropsychiatry and the future of diagnosis: a 'PC' model of the mind.
    Charlton BG
    Br J Psychiatry; 1995 Aug; 167(2):149-53; discussion 153-8. PubMed ID: 7582663
    [No Abstract]   [Full Text] [Related]  

  • 3. Limitations of cognitive status exams: a case-based discussion.
    Hawkins KA; Cooper ME
    Psychiatry; 1996; 59(4):382-8. PubMed ID: 9029659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive function and insight in schizophrenia: support for an association with impairments in executive function but not with impairments in global function.
    Lysaker PH; Bell MD; Bryson G; Kaplan E
    Acta Psychiatr Scand; 1998 Apr; 97(4):297-301. PubMed ID: 9570491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NUCOG: validity and reliability of a brief cognitive screening tool in neuropsychiatric patients.
    Walterfang M; Siu R; Velakoulis D
    Aust N Z J Psychiatry; 2006; 40(11-12):995-1002. PubMed ID: 17054568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the neurocognitive profiles of individuals with elevated psychotic or depressive symptoms.
    Grossman M; Best MW; Harrison AG; Bowie CR
    Early Interv Psychiatry; 2019 Aug; 13(4):928-934. PubMed ID: 29968389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychometric differentiation of schizophrenic and schizoaffective psychoses].
    Bühler KE; Gross M; Jürgensen R
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(6):535-52. PubMed ID: 1722906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill, and non-ill subjects.
    Candilis PJ; Fletcher KE; Geppert CM; Lidz CW; Appelbaum PS
    Schizophr Res; 2008 Feb; 99(1-3):350-8. PubMed ID: 18164593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Mini-Mental State Examination (MMSE) in long-stay patients with schizophrenia or schizoaffective disorders in a psychiatric institute.
    Ong HL; Subramaniam M; Abdin E; Wang P; Vaingankar JA; Lee SP; Shafie S; Seow E; Chong SA
    Psychiatry Res; 2016 Jul; 241():256-62. PubMed ID: 27203153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological screening in the psychiatric emergency room.
    Galynker II; Harvey PD
    Compr Psychiatry; 1992; 33(5):291-5. PubMed ID: 1395548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological prognosis and clinical recovery.
    Silverstein ML; Harrow M; Bryson GJ
    Psychiatry Res; 1994 Jun; 52(3):265-72. PubMed ID: 7991720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-specific differences in neurocognitive performance in psychotic disorders?].
    Selva G; Tabarés R; Salazar J; Balanzá V; Ballester F; Cózar R; Leal C
    Actas Esp Psiquiatr; 2000; 28(5):312-24. PubMed ID: 11269910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiences with "Schedules for Clinical Assessment in Neuropsychiatry (SCAN)" within the scope of a multicenter field study].
    Maurer K; Hillig A; Freyberger HJ; Velthaus S
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(3):235-45. PubMed ID: 1713350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normality and abnormality in behavioural aspect.
    Rhi BY
    Acta Neurochir (Wien); 1995; 132(4):164-8. PubMed ID: 8571785
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of the Mini-Mental State Examination in predicting neuropsychological functioning in a psychiatric sample.
    Faustman WO; Moses JA; Csernansky JG
    Acta Psychiatr Scand; 1990 Feb; 81(2):126-31. PubMed ID: 2327274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of neurocognitive impairments among children with psychiatric disorders: diagnosis and situational specificity.
    Szatmari P; Offord DR; Siegel LS; Finlayson MA; Tuff L
    J Child Psychol Psychiatry; 1990 Jan; 31(2):287-99. PubMed ID: 2312654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.